Krebs Biochemicals & Industries Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 99.24 million compared to INR 53.95 million a year ago. Revenue was INR 107.7 million compared to INR 67.83 million a year ago.

Net loss was INR 81.37 million compared to INR 94.24 million a year ago. Basic loss per share from continuing operations was INR 3.77 compared to INR 4.37 a year ago. Diluted loss per share from continuing operations was INR 3.77 compared to INR 4.37 a year ago.